1. To investigate the possible causes of Central Nervous System disorders
2. To design and implement Preventive Programs for diseases of the Central Nervous System.
3. To establish pioneering therapeutic strategies.
In this line of action, EuroEspes is the first group worldwide to design a clinical protocol for the diagnosis of diseases of the Central Nervous System, linked with a multifactorial therapeutic strategy for senile dementia and a pharmacogenomic intervention program for Alzheimer’s disease.
Diagnosis Protocols for CNS Diseases
396KB
EuroEspes is the first Spanish institution to carry out Phase II clinical trials with pioneering molecules for the treatment of Alzheimer’s disease, which are currently competitive on a worldwide level.
EuroEspes has developed other internationally leading products, and has a score of potential products of its own design under research, these being for the treatment of pathologies of the Central Nervous System and other systemic diseases with a high incidence in the population.
See Most Common Pathologies
Origin of our Patients
